These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33718210)

  • 1. Microscopic Invasion of Nerve Is Associated With Aggressive Behaviors in Pancreatic Neuroendocrine Tumors.
    Zhou H; Wang Y; Guo C; Li X; Cui W; Wang Z; Chen X
    Front Oncol; 2021; 11():630316. PubMed ID: 33718210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between pain and WHO grade of pancreatic neuroendocrine neoplasms: A multicenter study.
    Wang C; Lin T; Chen X; Cui W; Guo C; Wang Z; Chen X
    Cancer Biomark; 2023; 36(4):279-286. PubMed ID: 36938727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The associations between serum high-density lipoprotein cholesterol levels and malignant behavior in pancreatic neuroendocrine neoplasms.
    Quan L; Liu Y; Cui W; Wang X; Zhang W; Wang Z; Guo C; Lu C; Hu F; Chen X
    Lipids Health Dis; 2022 Jul; 21(1):58. PubMed ID: 35842659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A New Scoring System to Predict Recurrent Disease in Grade 1 and 2 Nonfunctional Pancreatic Neuroendocrine Tumors.
    Genç CG; Jilesen AP; Partelli S; Falconi M; Muffatti F; van Kemenade FJ; van Eeden S; Verheij J; van Dieren S; van Eijck CHJ; Nieveen van Dijkum EJM
    Ann Surg; 2018 Jun; 267(6):1148-1154. PubMed ID: 28594340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Textural analysis on contrast-enhanced CT in pancreatic neuroendocrine neoplasms: association with WHO grade.
    Guo C; Zhuge X; Wang Z; Wang Q; Sun K; Feng Z; Chen X
    Abdom Radiol (NY); 2019 Feb; 44(2):576-585. PubMed ID: 30182253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD56 Expression Is Associated with Biological Behavior of Pancreatic Neuroendocrine Neoplasms.
    Chen X; Guo C; Cui W; Sun K; Wang Z; Chen X
    Cancer Manag Res; 2020; 12():4625-4631. PubMed ID: 32606955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic neuroendocrine neoplasms at magnetic resonance imaging: comparison between grade 3 and grade 1/2 tumors.
    Guo C; Chen X; Xiao W; Wang Q; Sun K; Wang Z
    Onco Targets Ther; 2017; 10():1465-1474. PubMed ID: 28331340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Staging accuracy of MR for pancreatic neuroendocrine tumor and imaging findings according to the tumor grade.
    Kim JH; Eun HW; Kim YJ; Han JK; Choi BI
    Abdom Imaging; 2013 Oct; 38(5):1106-14. PubMed ID: 23728305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of the aggressiveness of non-functional pancreatic neuroendocrine tumors based on the dual-tracer PET/CT.
    Majala S; Seppänen H; Kemppainen J; Sundström J; Schalin-Jäntti C; Gullichsen R; Schildt J; Mustonen H; Vesterinen T; Arola J; Kauhanen S
    EJNMMI Res; 2019 Dec; 9(1):116. PubMed ID: 31872324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of preoperative peripheral blood neutrophil/lymphocyte ratio for lymph node metastasis in patients of resectable pancreatic neuroendocrine tumors: a nomogram-based study.
    Tong Z; Liu L; Zheng Y; Jiang W; Zhao P; Fang W; Wang W
    World J Surg Oncol; 2017 May; 15(1):108. PubMed ID: 28558772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact and Clinical Predictors of Lymph Node Metastases in Nonfunctional Pancreatic Neuroendocrine Tumors.
    Jiang Y; Jin JB; Zhan Q; Deng XX; Shen BY
    Chin Med J (Engl); 2015 Dec; 128(24):3335-44. PubMed ID: 26668149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Risk Factors for Distant and Lymph Node Metastasis of Pancreatic Neuroendocrine Tumors.
    Molasy B; Zemła P; Mrowiec S; Grudzińska E; Kuśnierz K
    Ther Clin Risk Manag; 2022; 18():745-752. PubMed ID: 35937972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Grade 3 Pancreatic Neuroendocrine Tumors on MDCT: Establishing a Diagnostic Model and Comparing Survival Against Pancreatic Ductal Adenocarcinoma.
    Chen HY; Zhang XY; Deng XY; Ge YL; Tang YQ; Cui H; Yang B; Pan Y; Shi D; Yu RS
    AJR Am J Roentgenol; 2020 Aug; 215(2):390-397. PubMed ID: 32432906
    [No Abstract]   [Full Text] [Related]  

  • 14. [A nomogram for predicting lymph node metastasis in early gastric cancer].
    Cui H; Cao B; Deng H; Liu GB; Liang WQ; Xie TY; Ye L; Zhang QP; Wang N; Liu FD; Wei B
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jan; 25(1):40-47. PubMed ID: 35067033
    [No Abstract]   [Full Text] [Related]  

  • 15. Correlation of computed tomography imaging features and pathological features of 41 patients with pancreatic neuroendocrine tumors.
    Utsumi M; Umeda Y; Takagi K; Takashi K; Nobuoka D; Yoshida R; Shinoura S; Sadamori H; Yagi T; Fujiwara T
    Hepatogastroenterology; 2015; 62(138):441-6. PubMed ID: 25916078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of recurrence after surgery based on preoperative MRI features in patients with pancreatic neuroendocrine tumors.
    Han S; Kim JH; Yoo J; Jang S
    Eur Radiol; 2022 Apr; 32(4):2506-2517. PubMed ID: 34647178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors for pancreatic neuroendocrine neoplasms (pNET) and the risk of small non-functioning pNET.
    Lombardi M; De Lio N; Funel N; Sardella C; Russo D; Urbani C; Rossi G; Campani D; Martino E; Marcocci C; Boggi U; Bogazzi F
    J Endocrinol Invest; 2015 Jun; 38(6):605-13. PubMed ID: 25501604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microscopic venous invasion in patients with pancreatic neuroendocrine tumor as a potential predictor of postoperative recurrence.
    Nanno Y; Toyama H; Otani K; Asari S; Goto T; Terai S; Ajiki T; Zen Y; Fukumoto T; Ku Y
    Pancreatology; 2016; 16(5):882-7. PubMed ID: 27350059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasible laparoscopic distal pancreatectomy for pancreatic neuroendocrine tumors.
    Shiozaki H; Shirai Y; Horiuchi T; Yasuda J; Furukawa K; Onda S; Gocho T; Shiba H; Ikegami T
    Mol Clin Oncol; 2021 Jun; 14(6):111. PubMed ID: 33903817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of risk factors for recurrence after curative resection of well-differentiated pancreatic neuroendocrine tumors based on the new grading classification.
    Tsutsumi K; Ohtsuka T; Fujino M; Nakashima H; Aishima S; Ueda J; Takahata S; Nakamura M; Oda Y; Tanaka M
    J Hepatobiliary Pancreat Sci; 2014 Jun; 21(6):418-25. PubMed ID: 24142395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.